Primary |
Product Used For Unknown Indication |
25.5% |
Blood Cholesterol Increased |
18.3% |
Hyperlipidaemia |
16.3% |
Hypercholesterolaemia |
13.4% |
Hypertension |
4.6% |
Blood Cholesterol |
4.0% |
Drug Use For Unknown Indication |
3.8% |
Dyslipidaemia |
1.6% |
Coronary Artery Disease |
1.5% |
Type Iib Hyperlipidaemia |
1.5% |
Depression |
1.3% |
Prophylaxis |
1.3% |
Breast Cancer Metastatic |
1.0% |
Diabetes Mellitus |
1.0% |
Low Density Lipoprotein Increased |
0.9% |
Angina Pectoris |
0.8% |
Cerebrovascular Accident |
0.8% |
Atrial Fibrillation |
0.7% |
Blood Cholesterol Abnormal |
0.7% |
Bronchiolitis |
0.6% |
|
Myalgia |
21.6% |
Rhabdomyolysis |
11.5% |
Pain In Extremity |
5.6% |
Vomiting |
5.6% |
Rash |
5.2% |
Tendon Rupture |
4.8% |
Weight Decreased |
4.8% |
Product Substitution Issue |
4.1% |
Palpitations |
3.7% |
Tendonitis |
3.7% |
Muscle Spasms |
3.3% |
Vision Blurred |
3.3% |
Interstitial Lung Disease |
3.0% |
Nausea |
3.0% |
Somnolence |
3.0% |
Swelling Face |
3.0% |
Urticaria |
3.0% |
Amnesia |
2.6% |
Drug Interaction |
2.6% |
Polymyositis |
2.6% |
|
Secondary |
Product Used For Unknown Indication |
29.6% |
Drug Use For Unknown Indication |
16.0% |
Hypertension |
10.5% |
Blood Cholesterol Increased |
7.7% |
Hypercholesterolaemia |
7.3% |
Hyperlipidaemia |
6.5% |
Unevaluable Event |
2.7% |
Diabetes Mellitus |
2.3% |
Blood Pressure |
2.0% |
Pain |
1.8% |
Dyslipidaemia |
1.7% |
Hiv Infection |
1.6% |
Blood Cholesterol |
1.6% |
Depression |
1.5% |
Cerebrovascular Accident |
1.5% |
Type 2 Diabetes Mellitus |
1.4% |
Blood Cholesterol Abnormal |
1.3% |
Atrial Fibrillation |
1.1% |
Heart Transplant |
1.1% |
Lipid Metabolism Disorder |
0.9% |
|
Rhabdomyolysis |
13.7% |
Myalgia |
9.0% |
Weight Decreased |
6.7% |
Death |
6.3% |
Vomiting |
6.3% |
Thrombocytopenia |
6.0% |
Rash |
5.7% |
Toxicity To Various Agents |
4.7% |
Pain In Extremity |
4.3% |
Vision Blurred |
4.3% |
Abnormal Dreams |
4.0% |
Pancreatitis Acute |
4.0% |
Renal Failure |
4.0% |
Completed Suicide |
3.7% |
Transaminases Increased |
3.3% |
Interstitial Lung Disease |
3.0% |
Nausea |
3.0% |
Sleep Disorder |
2.7% |
Urticaria |
2.7% |
Vasculitis |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
36.6% |
Drug Use For Unknown Indication |
14.1% |
Hypertension |
10.4% |
Blood Cholesterol Increased |
5.7% |
Diabetes Mellitus |
3.6% |
Rheumatoid Arthritis |
3.3% |
Depression |
2.9% |
Pain |
2.7% |
Atrial Fibrillation |
2.7% |
Type 2 Diabetes Mellitus |
2.2% |
Gastrooesophageal Reflux Disease |
2.0% |
Prophylaxis |
1.9% |
Hiv Infection |
1.8% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Osteoporosis |
1.6% |
Cardiac Disorder |
1.5% |
Blood Cholesterol |
1.5% |
Hypercholesterolaemia |
1.3% |
Hyperlipidaemia |
1.3% |
Anxiety |
1.2% |
|
Vomiting |
10.5% |
Weight Decreased |
7.9% |
Weight Increased |
7.8% |
Flushing |
7.4% |
Pruritus |
5.7% |
Drug Ineffective |
5.6% |
Nausea |
5.6% |
Death |
4.8% |
Dyspnoea |
4.7% |
Renal Failure Acute |
4.5% |
Pain |
4.4% |
Myocardial Infarction |
4.2% |
Pain In Extremity |
3.7% |
Urinary Tract Infection |
3.6% |
Pneumonia |
3.6% |
Syncope |
3.4% |
Pyrexia |
3.3% |
Headache |
3.2% |
Vision Blurred |
3.2% |
Malaise |
3.1% |
|
Interacting |
Product Used For Unknown Indication |
17.0% |
Mental Disorder |
13.6% |
Hypertension |
8.5% |
Somatoform Disorder |
6.8% |
Coronary Artery Disease |
6.0% |
Antiretroviral Therapy |
5.1% |
Blood Cholesterol Increased |
5.1% |
Hyperlipidaemia |
4.3% |
Drug Use For Unknown Indication |
3.8% |
Bronchiolitis |
3.4% |
Depression |
3.4% |
Herpes Zoster |
3.4% |
Lipodystrophy Acquired |
3.4% |
Menopause |
3.4% |
Hypercholesterolaemia |
3.0% |
Prophylaxis Against Transplant Rejection |
2.6% |
Arthritis |
2.1% |
Gout |
2.1% |
Hypothyroidism |
1.7% |
Angina Pectoris |
1.3% |
|
Drug Interaction |
27.0% |
Rhabdomyolysis |
13.5% |
Suicidal Ideation |
10.8% |
Akathisia |
5.4% |
Back Pain |
2.7% |
Blood Glucose Fluctuation |
2.7% |
Blood Glucose Increased |
2.7% |
Coronary Artery Disease |
2.7% |
Cytolytic Hepatitis |
2.7% |
Dementia |
2.7% |
Dizziness |
2.7% |
Drug Label Confusion |
2.7% |
Dyskinesia |
2.7% |
Erectile Dysfunction |
2.7% |
Extrapyramidal Disorder |
2.7% |
High Density Lipoprotein Decreased |
2.7% |
Multi-organ Failure |
2.7% |
Muscular Weakness |
2.7% |
Nausea |
2.7% |
Pain In Extremity |
2.7% |
|